The OneSight EssilorLuxottica Foundation, an international leader in inclusive vision care, has partner with the World Health Organization (WHO) to expand eye health services across NITI Aayog's aspirational blocks.
Neuberg Diagnostics, has added a Wellness Centre and Processing Lab to its list of facilities in Chennai. This new Wellness Centre in Abhiramapuram was inaugurated by Dr. Sengottuvelu G, Senior Consultant and Interventional Cardiologist at Apollo
Biocon Pharma Limited which is its fully controlled subsidiary along with Carnegie Pharmaceuticals LLC has been given approval by the US Food and Drug Administration (USFDA) to file the Abbreviated New Drug Application
Roche and KlinRisk have announced that they received a CE mark for the Kidney Klinrisk Algorithm, the first AI-based risk stratification tool for determining progressive decline in kidney function. The CE mark for the Kidney Klinrisk Algorithm...
Abbott, a global healthcare leader, has announced the launch of its AVEIR Dual Chamber (DR) leadless pacemaker system. It is the first dual-chamber leadless pacemaker system in the world that is engineered to help the heart beat in a more...
AstraZeneca Pharma India has been given the green light by the Central Drugs Standard Control Organisation (CDSCO) to import, market, and distribute Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder, branded as Enhertu.
One of the major steps to reinforce international cooperation on traditional medicine is the World Health Organization (WHO) along with the Government of India signing a Memorandum of Understanding
Apollo Healthcare Academy and Mahindra University, Hyderabad, have established a Memorandum of Understanding (MoU) to jointly offer Bachelor’s programmes in Allied Health Education to mitigate the unsatisfied need for skilled health professionals...
The government has initiated the application process for research and innovation projects under Pharma-MedTech Innovation Scheme to make this sector globally competitive and innovation-driven...
Wockhardt, a pharmaceutical company based in Mumbai, has received a new drug application (NDA) in the US, Food and Drug Administration (FDA), for its new antibacterial agent, Zidebactam-Cefepime injection (WCK 5222, ZAYNICH).
.jpg)
, CDSCO.jpg)